Scientists probe Placenta's role in protecting premature Babies' eyesight
NCT ID NCT04819893
Summary
This study aims to understand how certain fats (omega-3 fatty acids) and how the placenta processes them might be connected to an eye disease called retinopathy of prematurity (ROP) in very premature babies. Researchers will compare mothers who give birth very early (before 29 weeks) with mothers who give birth at full term, measuring levels of fatty acid receptors in the placenta. The goal is to gather knowledge about the biological mechanisms behind ROP, not to test a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourogne
RECRUITINGDijon, 21000, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.